Invesco’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.93M | Buy |
167,305
+50,184
| +43% | +$2.68M | ﹤0.01% | 1848 |
|
|
2025
Q1 | $4.74M | Buy |
117,121
+18,658
| +19% | +$755K | ﹤0.01% | 2177 |
|
|
2024
Q4 | $2.74M | Buy |
98,463
+21,086
| +27% | +$587K | ﹤0.01% | 2493 |
|
|
2024
Q3 | $2.22M | Sell |
77,377
-38,411
| -33% | -$1.1M | ﹤0.01% | 2553 |
|
|
2024
Q2 | $2.72M | Buy |
115,788
+75,937
| +191% | +$1.78M | ﹤0.01% | 2461 |
|
|
2024
Q1 | $1.01M | Buy |
39,851
+11,400
| +40% | +$288K | ﹤0.01% | 2977 |
|
|
2023
Q4 | $664K | Sell |
28,451
-224,102
| -89% | -$5.23M | ﹤0.01% | 3068 |
|
|
2023
Q3 | $12.8M | Buy |
252,553
+16,104
| +7% | +$815K | ﹤0.01% | 1598 |
|
|
2023
Q2 | $11M | Buy |
236,449
+217,796
| +1,168% | +$10.2M | ﹤0.01% | 1747 |
|
|
2023
Q1 | $714K | Sell |
18,653
-184,375
| -91% | -$7.05M | ﹤0.01% | 3062 |
|
|
2022
Q4 | $11.1M | Sell |
203,028
-34,858
| -15% | -$1.91M | ﹤0.01% | 1773 |
|
|
2022
Q3 | $8.1M | Buy |
+237,886
| New | +$8.1M | ﹤0.01% | 1931 |
|
|
2022
Q2 | – | Sell |
-10,585
| Closed | -$150K | – | 4002 |
|
|
2022
Q1 | $150K | Buy |
10,585
+156
| +1% | +$2.21K | ﹤0.01% | 3782 |
|
|
2021
Q4 | $221K | Sell |
10,429
-1,227
| -11% | -$26K | ﹤0.01% | 3705 |
|
|
2021
Q3 | $260K | Buy |
11,656
+1,627
| +16% | +$36.3K | ﹤0.01% | 3662 |
|
|
2021
Q2 | $249K | Buy |
+10,029
| New | +$249K | ﹤0.01% | 3681 |
|